Skip to main content

Table 3 Detailed information of adult MMD patients with postoperative CHS

From: Risk factors of postoperative cerebral hyperperfusion syndrome and its relationship with clinical prognosis in adult patients with moyamoya disease

No.

Sex

Age (yrs)

HT

Presentation

Smoking

Ss

Mv

Pc

Sx

OT

Treatment

Discharged mRs

1

M

58

Yes

TIA

No

4

D

4→3

Headache

P1

BP control

1

2

M

44

No

Headache

No

4

D

2→2

Dysarthria

P2

BP control

1

3

M

24

No

TA

No

3

D

4→2

Hemorrhage

P2

HE→ICU

1

4

M

41

No

Bleeding

No

3

D

2→2

Headache

P3

BP control

1

5

F

54

Yes

TIA

Yes

6

N

2→2

Motor disorder

P1

BP control

2

6

F

33

Yes

Infarction

No

3

D

3→2

Headache

P3

BP control

1

7

M

30

No

Infarction

No

4

D

4→3

Hemorrhage

P3

HE→ICU

2

8

F

21

No

TIA

No

3

D

2→2

Dysarthria

P2

BP control

2

9

F

35

No

Infarction

No

5

S

3→2

Seizure

P5

BP control

1

10

F

46

Yes

Infarction

Yes

4

D

3→1

Hemorrhage

P1

HE→ICU

2

11

M

41

Yes

Bleeding

Yes

3

D

4→2

Dysarthria

P2

BP control

1

12

F

34

No

Infarction

No

4

S

3→2

Hemorrhage

P3

BP control

2

  1. HT hypertension, Ss Suzuki stage, Mv moyamoya, D dense, N none, S sparse, Pc perfusion change (pre-operation → post-operation), Sx symptom, OT onset time, BP blood pressure, HE hematoma evacuation